Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo

Oncology Letters

Volumn 5, Issue 5, 2013, Pages 1567-1571

  Yan, Kun Huang ^a   Lin, Yung Wei ^a   Hsiao, Chi Hao ^a   Wen, Yu Ching ^a   Lin, Ke Hsun ^a   Liu, Chung Chi ^a   Hsieh, Mao Chih ^b   Yao, Chih Jung ^c,d   Yan, Ming De ^a   Lai, Gi Ming ^a,c,d   Chuang, Shuang En ^e   Lee, Liang Ming ^a,f  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b Division of general surgery   (Taiwan)

^c Wan Fang Hospital   (Taiwan)

^d Center of Excellence for Cancer Research   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Glutathione; Mefloquine; Prostate cancer; Reactive oxygen species

Indexed keywords

CYCLIN D1; LIPOCORTIN 5; MEFLOQUINE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL CYCLE REGULATION; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; WESTERN BLOTTING;

EID: 84875716471     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1259     Document Type: Article

References (18)

1. Sotelo J, Briceño E and López-González MA: Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 144: 337-343, 2006.
2. Briceño E, Reyes S and Sotelo J: Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine. Neurosurg Focus 14: e3, 2003.
3. Geng Y, Kohli L, Klocke BJ and Roth KA: Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. Neuro Oncol 12: 473-481, 2010.
4. Sharma N, Thomas S, Golden EB, Hofman FM, Chen TC, PetasisNA, Schönthal AH and Louie SG: Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett: 326: 143-154, 2012.
5. Taylor WR and White NJ: Antimalarial drug toxicity: a review. Drug Saf 27: 25-61, 2004.
6. ter Kuile FO, Nosten F, Thieren M, Luxemburger C, EdsteinMD, Chongsuphajaisiddhi T, Phaipun L, Webster HK and White NJ: High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis 166: 1393-1400, 1992.
7. Krudsood S, Looareesuwan S, Wilairatama P, Leowattana W, Tangpukdee N, Chalermrut K, Ramanathan S, Navaratnam V, Olliaro P, Vaillant M, Kiechel JR and Taylor WR: Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand. Trop Med Int Health 16: 458-465, 2011.
8. Dow GS, Caridha D, Goldberg M, Wolf L, Koenig ML, YourickDL and Wang Z: Transcriptional profiling of mefloquine-induced disruption of calcium homeostasis in neurons invitro. Genomics86: 539-550, 2005.
9. Simpson JA, Price R, ter Kuile F, Teja-Isavatharm P, NostenF, Chongsuphajaisiddhi T, Looareesuwan S, Aarons L and WhiteNJ: Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clin Pharmacol Ther 66: 472-484, 1999.
10. Kollaritsch H, Karbwang J, Wiedermann G, Mikolasek A, Na-Bangchang K and Wernsdorfer WH: Mefloquine concentration profiles during prophylactic dose regimens. Wien Klin Wochenschr 112: 441-447, 2000.
11. Bajgelman MC and Strauss BE: The DU145 human prostate carcinoma cell line harbors a temperature-sensitive allele of p53. Prostate 66: 1455-1462, 2006.
12. Isaacs WB, Carter BS and Ewing CM: Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 51: 4716-4720, 1991.
13. Keepers YP, Pizao PE, Peters GJ, van Ark-Otte J, Winograd B and Pinedo HM: Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for invitro chemosensitivity testing. Eur J Cancer 27: 897-900, 1991.
14. Abbas T and Dutta A: p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414, 2009.
15. Hood JE, Jenkins JW, Milatovic D, Rongzhu L and Aschner M: Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons. Neurotoxicology 31: 518-523, 2010.
16. Di Stefano A, Frosali S, Leonini A, Ettorre A, Priora R, DiSimplicio FC and Di Simplicio P: GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells. Biochim Biophys Acta 1763: 214-225, 2006.
17. Skulachev VP: Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis 11: 473-485, 2006.
18. Choi K, Kim J, Kim GW and Choi C: Oxidative stress-induced necrotic cell death via mitochondria-dependent burst of reactive oxygen species. Curr Neurovasc Res 6: 213-222, 2009.